Just received 75% of my requested allocation. Seems significantly oversubscribed.
- Forums
- IPOs
- BCAL Diagnostics IPO
BCAL Diagnostics IPO, page-27
Featured News
Featured News
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online